CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in EWTX — Edgewise Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in EWTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,212,215
+$6,428,450 QoQ
Shares Held
620,532
+4.1% QoQ
Ownership
0.571%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 223 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. EWTX ranks #60 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in EWTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,212,215 | 620,532 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,783,765 | 596,310 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,171,493 | 611,384 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,693,120 | 597,603 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $7,592,053 | 579,104 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $11,467,742 | 521,261 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $14,347,485 | 537,359 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $13,934,475 | 522,086 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $10,287,257 | 571,197 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,068,234 | 497,162 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,621,785 | 331,059 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,895,822 | 330,859 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,409,258 | 310,872 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,963,054 | 294,311 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,654,062 | 296,875 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,995,286 | 202,773 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $917,405 | 115,252 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,409,458 | 145,305 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,145,235 | 140,395 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,396,226 | 84,110 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,729,308 | 81,074 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||